Lilly, Scribe team up for neuro diseases CRISPR therapies
rommma Scribe Therapeutics is collaborating with Eli Lilly's unit (NYSE:LLY) Prevail Therapeutics and granted rights to its CRISPR X-Editing (XE) ...
rommma Scribe Therapeutics is collaborating with Eli Lilly's unit (NYSE:LLY) Prevail Therapeutics and granted rights to its CRISPR X-Editing (XE) ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.